蔚蓝生物子公司拟收购艾地盟蔚蓝生物科技(山东)有限公司50%股权

Core Viewpoint - The company announced a transaction involving the acquisition of a 50% stake in a subsidiary from ADM Singapore for a total price of 47 million yuan [1] Group 1 - The full subsidiary involved in the transaction is Qingdao Weilan Biological Group Co., Ltd. [1] - The acquired entity is Aidi Meng Weilan Biotechnology (Shandong) Co., Ltd. [1] - The transaction is part of the company's strategic moves to enhance its business operations [1]